TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Pds Biotechnology Corporation
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

PDS Biotechnology announced a registered direct offering of 5.8 million shares and warrants, expecting to raise $5.3 million upfront with potential additional $5.8 million from warrant exercises. The proceeds will support the VERSATILE-003 Phase 3 clinical trial and other research and development expenses.

Insights
EDGE   positive

Company is raising capital to advance its clinical trials, demonstrating ongoing development and potential growth in its immunotherapy research